Skip to content


  • Case Report
  • Open Access

Hand, foot, and mouth syndrome in an immunocompetent adult: a case report

  • 1Email author,
  • 2,
  • 2,
  • 2,
  • 2 and
  • 2
BMC Research Notes20136:441

  • Received: 7 February 2013
  • Accepted: 23 October 2013
  • Published:



Hand, foot, and mouth syndrome (HFMS) is a common acute illness. It is characterized by mild clinical symptoms including fever, blisters, and sores in the mouth and on the palms and soles following a 3- to 7-day incubation period. This syndrome is rarely seen in adults.

Case presentation

A 35-year-old male Caucasian patient had a history of multiple episodes of acute pharyngitis, hypertension, hypercholesterolemia, and occasional abdominal pain. He presented with polyarthralgia in the knees and hands and odynophagia, followed by fever, oral mucosal aphthous lesions, and vesicles on the palms and soles. Three weeks after presentation, he was admitted to the emergency room with acute myocarditis. The in-hospital evaluation revealed positive serology for coxsackie A9 (1:160), positive anti-transglutaminase and anti-gliadin antibodies, normal immunoglobulins, and human immunodeficiency virus negativity.


We herein describe a case of HFMS that was associated with coxsackie A9 infection complicated by acute myocarditis. Although an association between celiac disease and HFMS has not been described, this patient’s immunologic disruption could have favored the development of infection and ultimately HFMS.


  • Hand, foot, and mouth syndrome
  • Myopericarditis
  • Coxsackie A9
  • Celiac disease


Hand, foot, and mouth syndrome (HFMS) mainly affects children [1, 2]. It is characterized by mild clinical symptoms including fever and blisters and sores in the mouth and on the palms and soles following a 3- to 7-day incubation period, with recovery in 7 to 10 days [3]. It is caused by infection with an enterovirus, mainly enterovirus 71 (EV71) and coxsackie A16 (CA16) [4]. In a minority of cases, isolation of the agent is not possible [1]. We herein report an atypical presentation of HFMS in an immunocompetent adult.

Case presentation

A 35-year-old Caucasian male patient who worked as an environmental engineer had a medical history of recurrent episodes of acute pharyngitis, essential hypertension, hypercholesterolemia, and occasional abdominal pain and bloating. He had no recent travel history. His family history included immunoglobulin (Ig) A deficiency in his 18-month-old son and a several-year history of nonspecific colitis in his father. Regular medications were nifedipine CR (30 mg/day) and rosuvastatin (5 mg/day).

The patient initially presented to his family physician with a symmetrical polyarthralgia involving his knees and hands, odynophagia, temporal headache, retro-ocular pain, and an intermittent fever (maximum of 38°C). He was initially managed with an antibiotic (azithromycin) and anti-inflammatory agents without resolution of symptoms. One week later, he developed oral mucosal lesions and a vesicular rash on his palms and soles (Figures 1 and 2). In April 2011, 3 weeks after the initial presentation, he was admitted to the emergency room at the Curry Cabral Hospital (Lisbon) with compressive retrosternal pain, without dyspnea or a productive cough. The odynophagia was persistent, with worsening of the headache and arthralgia.
Figure 1
Figure 1

HFMS: oral vesicles.

Figure 2
Figure 2

HFMS: vesicular rash on palms.

The emergency staff noted nonexudative oropharyngitis and tender cervical lymphadenopathy with normal cardiorespiratory examination findings and absence of a pericardial friction rub. He had abdominal tenderness in the right lower quadrant without guarding. There were no vesicles on the palms of his hands or soles of his feet, but the skin had a scalded appearance. There was slight ST-segment depression on the inferior leads (II, III, and aVF) of the electrocardiogram (ECG) and mildly increased levels of troponin I and creatine kinase-MB fraction. The diagnosis of myopericarditis was considered. He started ibuprofen at 400 mg three times a day and was admitted for further workup.

As an inpatient, his condition slowly improved. His fever resolved and he was discharged with only slight fatigue during strenuous exercise. The skin vesicles disappeared and progressed to scaliness (Figure 3).
Figure 3
Figure 3

HFMS: skin with a scaly appearance, 1 week after the vesicular rash.

Laboratory examination showed positive serology for coxsackie A9 (IgM with a titer of 1:160) 1 week after the disappearance of the vesicular rash. It is assumed that a titer of >1:80 is predictive of a diagnosis of the infection in question. In addition, he was positive for IgA anti-transglutaminase 25 (<20 U/mL) and IgA anti-gliadin 77 (<25 U/mL) antibodies, with higher titers during follow-up after discharge (59 and 60 U/mL, respectively). He had normal immunoglobulin levels and was negative for antinuclear antibody (ANA), anti-DNA antibody (dsDNA), and p- and c-anti-neutrophil cytoplasmic antibody (ANCA). Serology for viral hepatitis and human immunodeficiency virus were negative. Endoscopy revealed a normal appearance of the gastric and duodenal mucosae, and biopsy showed slight mucosal architecture disruption.

An echocardiogram showed a normal left ventricle, slightly hypertrophic interventricular septum, normal systolic function (ejection fraction of 60%), and left atrium in the upper limit of the normal range. The ECG findings and cardiac biomarker levels returned to normal after 5 days.

To ameliorate the abdominal pain and bloating, a gluten-free diet was introduced, and this proved to be helpful with normalization of the anti-transglutaminase and anti-gliadin antibodies 6 months later.


To the best of our knowledge, HFMS in adults has rarely been reported [1, 57]. Previously reported cases had a typical presentation with mucocutaneous involvement, and one case was complicated by arthritis. Even in reports of HFMS epidemics in children, only one case of a generalized neonatal coxsackie A9 infection presenting with massive pleural effusion has been reported [1, 2, 8].

We herein reported a case of HFMS complicated by myopericarditis, which has not been previously described [1]. Coxsackie A9 is not the most common cause of HFMS among the epidemics that have occurred worldwide. Outbreaks due to EV71 were seen in the Asia Pacific region in 1997 and in Taiwan in 1998 [4]. In 2007, the same was observed in China, with seasonal outbreaks in later years [9].

The coxsackie B group is more commonly described as a cause of myopericarditis, although coxsackie A9 is also cardiotropic. A neurologic presentation and hepatic involvement have been reported in association with the latter virus [1012].

Many researchers are now studying risk factors for HFMS. Infectious disease control exercises and good hygiene practices are important to prevent the transmission of HFMS. In the present case, there was no close contact with individuals with similar symptoms. Geographic factors have been associated with incident cases as well as mortality, with severe cases associated with rural areas and more common in patients under 6 years of age and with a low level of medical care [1]. HFMS is reportedly more common in rainy seasons according to geographical location [5]. While outbreaks usually occur in summer or early fall in temperate countries, enterovirus surveillance in the US showed that EV71 and CA16 have an endemic pattern and that the majority of cases are reported during warmer seasons, between June and October [13]. In spite of these seasonal outbreaks, our case was reported in April and was not related to rainy weather or high temperatures. It was not possible to perform molecular diagnosis (RT-PCR) or viral culture in our case because the patient was admitted after the development of viremia and a vesicular rash.

There are no studies showing a relationship between celiac disease and HFMS; however, bearing its immunologic disruption [14], it may be associated with a higher risk for infection or a more symptomatic presentation than commonly seen in adults.



Authors’ Affiliations

Departments of Infectious Diseases, Hospital de Curry Cabral, Rua da Beneficência n.º 8, 1069-166 Lisbon, Portugal
Departments of Auto-immunity - Internal Medicine, Hospital de Curry Cabral, Lisbon, Portugal


  1. Zhang J, Chang Z, Zhang W, Wang Z, Feng Z: Characterization of Hand, Foot, and Mouth Disease in China between 2008 and 2009. Biomed Environ Sci. 2011, 24 (3): 214-221.PubMedGoogle Scholar
  2. Chang LY, Hsu KH, Ning HC, Tsao KC, Li CC: et al., Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. 2002, 109 (6): e88-10.1542/peds.109.6.e88.PubMedView ArticleGoogle Scholar
  3. Flett K, Youngster I, Huang J, McAdam A, Sandora TJ, Rennick M: et al., Hand, foot, and mouth disease caused by coxsackievirus A6 [letter]. Emerg Infect Dis [Internet]. 2012,,Google Scholar
  4. Ho M, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR: An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999, 341 (13): 929-35. 10.1056/NEJM199909233411301.PubMedView ArticleGoogle Scholar
  5. Zheng ZM, Caueffield D, Neumann M, Specter S, Baker CC, Bankowski MJ: Enterovirus 71 isolated from China is serologically similar to the prototype E71 BrCr strain but differs in the 5′-noncoding region. J Med Virol. 1995, 47 (2): 161-7. 10.1002/jmv.1890470209.PubMedView ArticleGoogle Scholar
  6. Shikuma E, Tanioka M, Matsumura Y, Miyachi Y: Letter: an adult case of hand-foot-mouth disease showing severe mucous involvement. Dermatol Online J. 2011, 17 (12): 15-PubMedGoogle Scholar
  7. Toya M, Tanizaki H, Fujisawa A, Tanioka M, Miyachi Y: An adult case of severe hand-foot-mouth disease accompanying persistent fever and systemic arthritis. Dermatol Online J. 2012, 18 (8): 14-PubMedGoogle Scholar
  8. Talsma M, Vegting M, Hess J: Generalised Coxsackie A9 infection in a neonate presenting with pericarditis. Br Heart J. 1984, 52 (6): 683-5. 10.1136/hrt.52.6.683.PubMedPubMed CentralView ArticleGoogle Scholar
  9. Center of Helth protection, H.K: Communicable diseases surveillance and response. Commun Dis Watch. 2012, 9: 13-Google Scholar
  10. Schultz JC, Cooper LC, Rihal CS: Diagnosis and Treatment of Viral Myocarditis. Mayo Clin Proc. 2009, 84 (11): 1001-1009.PubMedPubMed CentralView ArticleGoogle Scholar
  11. Grist NR, Bell EJ: Coxsackie virus heart diseases. Br Med J. 1968, 3 (5617): 556-PubMedPubMed CentralView ArticleGoogle Scholar
  12. Moreau B, Bastedo C, Michel RP, Ghali P: Hepatitis and Encephalitis due to Coxsackie Virus A9 in an Adult. Case Rep Gastroenterol. 2011, 5 (3): 617-22. 10.1159/000333135. 10.1159/000333135. Epub 2011 Oct 10PubMedPubMed CentralView ArticleGoogle Scholar
  13. Khetsuriani N, LaMonte-Fowlkes A, Oberste MS, Pallansch MA: Enterovirus Surveillance — United States, 1970–2005. Surveillance summary. MMWR: CDC. 2006, 55 (SS08): 1-20.Google Scholar
  14. Kagnoff M: Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest. 2007, 117 (1): 41-49. 10.1172/JCI30253.PubMedPubMed CentralView ArticleGoogle Scholar


© Flor de Lima et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.